Third Quarter and Nine Months Results 2007

Go to navigation
Go to content

Reference code :: wf5356
Published date :: 01 November 2007
Expired date :: 19 March 2035

“Nine Months sales up 7 percent, core EPS up 8 percent. On track to deliver full year earnings target.”

AstraZeneca PLC Third Quarter and Nine Months Results 2007

Download the narrative and figures .

Not signed in

Page tools

Share price

London: 26.95 GBP
New York: 44.82 USD
Stockholm: 310.10 SEK

At 21-Nov-2009 10:43 GMT

Detailed share price

Introduction to AstraZeneca

Our responsibility

We continue to communicate openly on a range of issues, including:

Contact us

Stay in touch

Subscribe via RSS

This website is intended for people seeking information on the AstraZeneca International business. If you are in the US you should visit AstraZeneca US.

We also have national business sites which can be found under our list of AstraZeneca websites.

We also have specific national and international websites designed for patients and healthcare professionals. If you have a question you can contact us.